CEACAM5 and pachyonychia congenita: CA19‐9, carcinoembryonic antigen CEA, glycotype antigen 125 are commonly used PC markers among which CA19‐9 is the most valuable tumor marker in PC, and the production of autoantibodies is related to the development and prognosis of PC.156, 157, 158